CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Open-market buy Chief Commercial Officer bought 10,525 shares at $4.72 ($49,678)
- 4 Open-market buy Director bought 10,000 shares at $4.83 ($48,300)
- 4 Open-market buy President, CEO and Director bought 10,000 shares at $4.83 ($48,300)
- 4 Open-market buy Director bought 2,000 shares at $4.83 ($9,660)
- 4 Open-market buy CFO and Chief Corp. Deve. Off. bought 2,000 shares at $4.53 ($9,060)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 300,000 shares at an average $9.10 ($2,729,332)
- 4 Open-market sale President, CEO and Director sold 300,000 shares at an average $9.10 ($2,729,332)
- 4 Open-market buy Director bought 2,500 shares at an average $10.79 ($26,986)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 12 · 235 filings